atenolol has been researched along with fumarates in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, R; Langguth, P; Merkle, HP; Werdenberg, D; Wolffram, S | 1 |
| Corynen, S; Dieterle, W; Mann, J; Vaidyanathan, S | 1 |
| Aubert, JF; Bouzourene, K; Hayoz, D; Mazzolai, L; Nussberger, J; Pellegrin, M | 1 |
| Bheda, M; Dechend, R; Dietz, R; Ford, J; Keefe, DL; Prescott, MF; Yu, CM | 1 |
| Ahn, J; Carriere, K; Chang, SA; Choe, YH; Chung, TY; Hwang, JW; Jang, SY; Ki, CS; Kim, DK; Kim, EK; Kim, SM; Sung, K | 1 |
3 trial(s) available for atenolol and fumarates
| Article | Year |
|---|---|
Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amides; Atenolol; Celecoxib; Cimetidine; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Drug Interactions; Enzyme Inhibitors; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Male; Middle Aged; Pyrazoles; Renin; Sulfonamides | 2005 |
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Atenolol; Blood Pressure; Demography; Diastole; Drug Therapy, Combination; Endpoint Determination; Female; Fumarates; Heart Rate; Humans; Hypertension; Male; Renin; Renin-Angiotensin System; Systole | 2008 |
Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amides; Aorta, Thoracic; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Fumarates; Humans; Male; Marfan Syndrome; Prospective Studies; Pulse Wave Analysis; Renin; Treatment Outcome; Vascular Stiffness; Vasodilation | 2018 |
2 other study(ies) available for atenolol and fumarates
| Article | Year |
|---|---|
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.
Topics: Animals; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Cells, Cultured; Dimethyl Fumarate; Enzyme Inhibitors; Fumarates; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Liver Extracts; Microvilli; Pancreatic Extracts; Propranolol; Psoriasis; Swine | 2003 |
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles | 2008 |